Abacavir Sulfate, Dolutegravir Sodium, Lamivudine (Triumeq)
Questions a plan sponsor actually asks.
What is Abacavir Sulfate, Dolutegravir Sodium, Lamivudine used for?
Abacavir Sulfate, Dolutegravir Sodium, Lamivudine is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Abacavir Sulfate, Dolutegravir Sodium, Lamivudine?
No. Abacavir Sulfate, Dolutegravir Sodium, Lamivudine is brand-only with no generic equivalents currently in market.
How much does my plan pay for Abacavir Sulfate, Dolutegravir Sodium, Lamivudine?
Across 329 Part D plans, Abacavir Sulfate, Dolutegravir Sodium, Lamivudine averages $130.01/unit (NADAC). Lowest available: $130.01/unit. Highest in distribution: $130.01/unit.
Is Abacavir Sulfate, Dolutegravir Sodium, Lamivudine on the FDA shortage list?
No. Abacavir Sulfate, Dolutegravir Sodium, Lamivudine is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.